| Literature DB >> 23723984 |
Xin Wang1, Jiawen Fan, Meng Zhang, Zhongcui Sun, Gezhi Xu.
Abstract
OBJECTIVE: The retina is subjected to tractional forces in various conditions. As the predominant glial element in the retina, Müller cells are active players in all forms of retinal injury and disease. In this study, we aim to identify patterns of gene expression changes induced by cyclic mechanical stretching in Müller cells.Entities:
Mesh:
Year: 2013 PMID: 23723984 PMCID: PMC3664568 DOI: 10.1371/journal.pone.0063467
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Up- and downregulated Genes (p<0.05, more than twofold change) in Müller cells after stretching for 1 h.
| Accession# | Gene | Gene Title | Fold |
| NM_017352 | Nr4a3 | Nuclear receptor subfamily 4, group A, member 3 | 15.14 |
| NM_133578 | Dusp5 | Dual specificity phosphatase 5 | 8.16 |
| NM_001008826 | LOC360231 | MHC class I RT1.O type 149 processed pseudogene | 7.29 |
| NM_012912 | Atf3 | Activating transcription factor 3 | 5.72 |
| NM_017123 | Areg | Amphiregulin | 5.47 |
| NM_138526 | Ccrn4l | CCR4 carbon catabolite repression 4-like | 5.43 |
| NM_017259 | Btg2 | BTG family, member 2 | 5.24 |
| NM_001108510 | Dusp8 | Dual specificity phosphatase 8 | 5.10 |
| NM_024388 | Nr4a1 | Nuclear receptor subfamily 4, group A, member 1 | 4.82 |
| XM_001056859 | Sprr1al | Small proline-rich protein 1A-like | 4.62 |
| NM_017259 | Btg2 | BTG family, member 2 | 4.43 |
| NM_021689 | Ereg | Epiregulin | 4.05 |
| NM_012945 | Hbegf | Heparin-binding EGF-like growth factor | 3.76 |
| NM_001014071 | Errfi1 | ERBB receptor feedback inhibitor 1 | 3.66 |
| NM_031707 | Homer1 | Homer homolog 1 (Drosophila) | 3.60 |
| NM_053883 | Dusp6 | Dual specificity phosphatase 6 | 3.53 |
| NM_012589 | IL6 | Interleukin 6 | 3.20 |
| NM_012603 | Myc | Myelocytomatosis oncogene | 3.11 |
| NM_053769 | Dusp1 | Dual specificity phosphatase 1 | 2.97 |
| NM_001079890 | Gprc5a | G protein-coupled receptor, family C, group 5, member A | 3.06 |
| NM_153724 | Rcan1 | Regulator of calcineurin 1 | 2.99 |
| NM_017180 | Phlda1 | Pleckstrin homology-like domain, family A, member 1 | 2.97 |
| NM_053633 | Egr2 | Early growth response 2 | 2.92 |
| NM_019328 | Nr4a2 | Nuclear receptor subfamily 4, group A, member 2 | 2.78 |
| NM_012953 | Fosl1 | Fos-like antigen 1 | 2.75 |
| NM_053713 | Klf4 | Kruppel-like factor 4 (gut) | 2.71 |
| NM_013058 | Id3 | Inhibitor of DNA binding 3 | 2.65 |
| NM_053382 | Tnfaip6 | Tumor necrosis factor alpha induced protein 6 | 2.56 |
| NM_001047858 | Srxn1 | Sulfiredoxin 1 homolog (S. cerevisiae) | 2.56 |
| NM_021835 | Jun | Jun oncogene | 2.35 |
| NM_031971 | Hspa1 | Heat shock 70kD protein 1 | 2.51 |
| NM_013153 | Has2 | Hyaluronan synthase 2 | 2.49 |
| NM_012620 | Serpine1 | Serine (or cysteine) peptidase inhibitor, clade E, member 1 | 2.48 |
| NM_001012046 | Spry2 | Sprouty homolog 2 | 2.43 |
| NM_031971 | Hspa1a | Heat shock 70kD protein 1A | 2.43 |
| NM_024381 | Gk | Glycerol kinase | 2.38 |
| NM_017232 | Ptgs2 | Prostaglandin-endoperoxide synthase 2 | 2.37 |
| XM_002728821 | LOC100360845 | Hypothetical protein LOC100360845 | 2.16 |
| NM_001110860 | Crem | cAMP responsive element modulator | 2.15 |
| NM_001014094 | Plscr2 | Phospholipid scramblase 2 | 2.14 |
| NM_019242 | Ifrd1 | Interferon-related developmental regulator 1 | 2.12 |
| NM_001169116 | RGD1306119 | Similar to transcriptional regulating protein 132 | 2.11 |
| NM_012620 | Serpine1 | Serine (or cysteine) peptidase inhibitor, clade E, member 1 | 2.09 |
| NM_023985 | Trib1 | Tribbles homolog 1 | 2.05 |
| NM_001047858 | Srxn1 | Sulfiredoxin 1 homolog | 2.05 |
| NM_017076 | PVR | Poliovirus receptor | 2.04 |
| NM_001108977 | Epha2 | Eph receptor A2 | 2.02 |
| NM_001106779 | Nedd1 | Neural precursor cell expressed, developmentally down-regulated 1 | 0.48 |
| XM_001077448 | Dact1 | Dapper, antagonist of beta-catenin, homolog 1 | 0.48 |
| NM_001107250 | Znf503 | Zinc finger protein 503 | 0.48 |
| NM_080906 | Ddit4 | DNA-damage-inducible transcript 4 | 0.46 |
| NM_013148 | Htr5a | 5-Hydroxytryptamine (serotonin) receptor 5A | 0.45 |
| XM_001072241 | Maml2 | Mastermind like 2 | 0.40 |
| NM_001008767 | Txnip | Thioredoxin interacting protein | 0.34 |
| NM_001108654 | Tox | Thymocyte selection-associated high mobility group box | 0.31 |
Fold change greater than 1.0 represents increases, while less than 1.0 indicates decreases in stretching versus control group.
Indicates gene expression result obtained from microarray analysis was further verified using qPCR.
Up- and downregulated Genes (p<0.05, more than twofold change) in Müller cells after stretching for 24 h.
| Accession# | Gene | Gene Title | Fold |
| NM_001106637 | Gem | GTP binding protein | 2.70 |
| XM_001063122 | LOC685277 | Similar to liver-specific bHLH-Zip transcription factor | 2.66 |
| NM_053346 | Nrn1 | neuritin 1 | 2.60 |
| NM_001191721 | Rps6ka6 | Ribosomal protein S6 kinase polypeptide 6 | 2.60 |
| NM_001109344 | RGD1562846 | Similar to Docking protein 5 (Downstream of tyrosine kinase 5) | 2.55 |
| NM_019176 | Stmn4 | Stathmin-like 4 | 2.40 |
| NM_053802 | Tgfbi | Transforming growth factor, beta induced | 2.33 |
| NM_001014193 | RGD1359529 | Similar to chromosome 1 open reading frame 63 | 2.28 |
| NM_001107464 | Dact2 | Dapper, antagonist of beta-catenin, homolog 2 | 2.28 |
| NM_001167840 | IL1rap | Interleukin 1 receptor accessory protein | 2.27 |
| NM_001134986 | Rnf180 | Ring finger protein 180 | 2.25 |
| NM_031522 | Neu1 | Sialidase 1 (lysosomal sialidase) | 2.20 |
| NM_130812 | Cdkn2b | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 2.19 |
| NM_001106909 | RGD1309095 | Similar to hypothetical protein BC015148 | 2.15 |
| NM_017094 | Ghr | Growth hormone receptor | 2.06 |
| NM_001106047 | Loxl2 | Lysyl oxidase-like 2 | 2.05 |
| NM_001106550 | Nkain4 | Na+/K+ transporting ATPase interacting 4 | 0.50 |
| NM_001106134 | Ska1 | Spindle and kinetochore associated complex subunit 1 | 0.50 |
| NM_019189 | Hapln1 | Hyaluronan and proteoglycan link protein 1 | 0.49 |
| NM_175578 | Rcan2 | Regulator of calcineurin 2 | 0.49 |
| NM_001107956 | Car9 | Carbonic anhydrase 9 | 0.49 |
| NM_019212 | Acta1 | Actin, alpha 1 | 0.49 |
| NM_022183 | Top2a | Topoisomerase (DNA) II alpha | 0.49 |
| NM_138502 | Mgll | Monoglyceride lipase | 0.48 |
| NM_001106623 | RGD1311164 | Similar to DNA segment, Chr 6 | 0.48 |
| NM_001039549 | Ugt1a | UDP glucuronosyltransferase 1 family, polypeptide A | 0.48 |
| NM_138905 | Ppap2b | Phosphatidic acid phosphatase type 2B | 0.48 |
| NM_031582 | Aoc3 | Amine oxidase, copper containing 3 (vascular adhesion protein 1) | 0.48 |
| NM_012545 | Ddc | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | 0.47 |
| NM_001106465 | Ntng1 | Netrin G1 | 0.47 |
| NM_012715 | Adm | Adrenomedullin | 0.46 |
| NM_001013222 | Rnd1 | Rho family GTPase 1 | 0.46 |
| NM_001106306 | Cpxm2 | Carboxypeptidase X (M14 family), member 2 | 0.45 |
| NM_001007648 | Cdca3 | Cell division cycle associated 3 | 0.45 |
| NM_181635 | Kif15 | Kinesin family member 15 | 0.45 |
| NM_012550 | Ednra | Endothelin receptor type A | 0.44 |
| NM_001108009 | Rasgrp3 | RAS guanyl releasing protein 3 (calcium and DAG-regulated) | 0.44 |
| NM_022183 | Top2a | Topoisomerase (DNA) II alpha | 0.44 |
| NM_024388 | Nr4a1 | Nuclear receptor subfamily 4, group A, member 1 | 0.44 |
| NM_172033 | Plekhb1 | Pleckstrin homology domain containing, family B (evectins) member 1 | 0.43 |
| NM_053848 | Opcml | Opioid binding protein/cell adhesion molecule-like | 0.43 |
| NM_138905 | Ppap2b | Phosphatidic acid phosphatase type 2B | 0.43 |
| XM_001078892 | Gbp4 | Guanylate binding protein 4 | 0.42 |
| NM_181087 | Cyp26b1 | Cytochrome P450, family 26, subfamily b, polypeptide 1 | 0.42 |
| XM_001069190 | RGD1563437 | Similar to KIAA1217 | 0.41 |
| NM_001011893 | 4-Sep | Septin 4 | 0.41 |
| NM_031834 | Sult1a1 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 | 0.41 |
| XM_001059692 | RGD1307396 | Similar to RIKEN cDNA 6330406I15 | 0.40 |
| NM_053633 | Egr2 | Early growth response 2 | 0.40 |
| XM_001056542 | LOC679475 | Hypothetical protein LOC679475 | 0.39 |
| NM_017226 | Padi2 | Peptidyl arginine deiminase, type II | 0.39 |
| NM_153737 | Sostdc1 | Sclerostin domain containing 1 | 0.39 |
| NM_013122 | Igfbp2 | Insulin-like growth factor binding protein 2 | 0.36 |
| NM_001107221 | C1qtnf7 | C1q and tumor necrosis factor related protein 7 | 0.34 |
| NM_022707 | Pln | Phospholamban | 0.34 |
| NM_022197 | Fos | FBJ osteosarcoma oncogene | 0.33 |
| NM_019292 | Car3 | Carbonic anhydrase 3 | 0.32 |
| NM_022257 | Masp1 | Mannan-binding lectin serine peptidase 1 | 0.31 |
| NM_031739 | Kcnd3 | Potassium voltage-gated channel, Shal-related subfamily, member 3 | 0.31 |
| NM_012598 | Lpl | Lipoprotein lipase | 0.30 |
| NM_021576 | Nt5e | 5′-Nucleotidase, ecto | 0.22 |
| NM_001135855 | Scara5 | Scavenger receptor class A, member 5 (putative) | 0.21 |
Fold change greater than 1.0 represents increases, while less than 1.0 indicates decreases in stretching versus control group.
Indicates gene expression result obtained from microarray analysis was further verified using qPCR.
Figure 1Hierarchical cluster analysis of differentially expressed genes (p<0.05, more than twofold change) at 1 and 24 h.
Each row represents a probe and each column represents one sample. The values represent the fold changes compared with the corresponding control. Positive and negative fold changes are shown in red and green, respectively, as shown in the color bar. S, stretching group; C, control group.
Figure 2Volcano plot of stretching vs. control at 1 and 24 h.
Each point represents a gene plotted as a function of fold change (Log2(fold change), x-axis) and statistical significance (-Log10(p-value), y-axis). The vertical dotted line represents twofold changes. The horizontal dotted line represents p = 0.05. The red dots represent selected differentially expressed genes with p<0.05 and more than twofold change.
Significantly changed pathways in Müller cells after stretching for 1 h.
| Pathway Name | Genes (n) | P-value |
| ErbB signaling pathway | 5 | 0.0000 |
| MAPK signaling pathway | 9 | 0.0000 |
| Jak-STAT signaling pathway | 3 | 0.0013 |
| Pathways in cancer | 4 | 0.0013 |
| Wnt signaling pathway | 3 | 0.0013 |
| Prion diseases | 2 | 0.0014 |
| Leishmania infection | 2 | 0.0042 |
| Colorectal cancer | 2 | 0.0051 |
| TGF-beta signaling pathway | 2 | 0.0067 |
| Small cell lung cancer | 2 | 0.0083 |
| Toll-like receptor signaling pathway | 2 | 0.0088 |
| GnRH signaling pathway | 2 | 0.009 |
| Antigen processing and presentation | 2 | 0.0104 |
| Spliceosome | 2 | 0.0154 |
| Thyroid cancer | 1 | 0.0441 |
| Endocytosis | 2 | 0.0458 |
Significantly changed pathways in Müller cells after stretching for 24 h.
| Pathway Name | Genes (n) | P-value |
| Glycerolipid metabolism | 3 | 0.0001 |
| Phenylalanine metabolism | 2 | 0.0004 |
| Nitrogen metabolism | 2 | 0.0008 |
| MAPK signaling pathway | 4 | 0.0013 |
| Tyrosine metabolism | 2 | 0.0016 |
| Sphingolipid metabolism | 2 | 0.0026 |
| Retinol metabolism | 2 | 0.0066 |
| B cell receptor signaling pathway | 2 | 0.0089 |
| Metabolic pathways | 6 | 0.0171 |
| Sulfur metabolism | 1 | 0.0203 |
| Vascular smooth muscle contraction | 2 | 0.0209 |
| Axon guidance | 2 | 0.0227 |
| Other glycan degradation | 1 | 0.0286 |
| beta-Alanine metabolism | 1 | 0.0385 |
| Nicotinate and nicotinamide metabolism | 1 | 0.0401 |
| Pentose and glucuronate interconversions | 1 | 0.0401 |
| Histidine metabolism | 1 | 0.0418 |
| Calcium signaling pathway | 2 | 0.0431 |
| Ascorbate and aldarate metabolism | 1 | 0.0434 |
| Homologous recombination | 1 | 0.0450 |
Figure 3Interaction networks of gene products induced by mechanical stretching at 1 and 24 h.
This diagram, prepared using Gene Spring Software, illustrates the known direct interactions between the proteins encoded by 56 genes at 1 h and 62 genes at 24 h (p<0.05, more than twofold change). IL 6, Hbegf, Ptgs2, and Myc at 1 h and Fos at 24 h show strong interaction centers. Ovals surrounded by blue lines represent proteins included in the above list.
Primers Used for qPCR.
| Gene Symbol | Genebank | Primer Sequence | Product Size (bp) | |
| Areg | NM_017123 | F: CGCAGCTATTGGCATCATTA R: | 71 | |
| Egr2 | NM_053633 | F: TCCTCTGTGCCTTGTGTGATG R: | 89 | |
| Jun | NM_021835 | F: GATTGCTTCTGTAGTGCTCCGTAA R: | 89 | |
| PVR | NM_017076 | F: CCAGTGTGGCGAACATAGCA R: | 68 | |
| Atf3 | NM_012912 | F: TTCCTTCCCACCAAAAACCA R: | 81 | |
| Myc | NM_012603 | F: GCTTCGAAACTCTGGTGCATAA R: | 73 | |
| Dusp1 | NM_053769 | F: TCGAGCCCCTCTGACAAAAC R: | 72 | |
| IL6 | NM_012589 | F: AATGGAGAAGTTAGAGTCACAGAAGGA R: | 106 | |
| Ptgs2 | NM_017232 | F: GAAGGCCCCGTAGGTATTTTA R: | 90 | |
| Epha2 | NM_001108977 | F: CTGGCCGACTTGTAGGAGACTT R: | 69 | |
| Hbegf | NM_012945 | F: CTGGCCCGCCTCTCTTG R: | 75 | |
| Has2 | NM_013153 | F: GCCTTGTGTGCAGTCCCATT R: | 72 | |
| Adm | NM_012715 | F: GGCAGAGGAACCCAAGATCA R: | 75 | |
| Loxl2 | NM_001106047 | F: CGATTGCCACCTCCTTGCTA R: | 77 | |
| Nrn1 | NM_053346 | F: AAGAGGTTGGGTATAGTAGGACAGGTT R: | 84 | |
| Fos | NM_022197 | F: CTCTTCAGCGTCCATGTTCA R: | 70 | |
| GAPDH | NM_017008 | F: TGGCCTCCAAGGAGTAAGAAAC R: | 69 | |
Validation of Microarray Gene Expression at 1 h by qPCR.
| Gene | Fold change (Mean±SD) | |
| Microarray (n = 3) | RT-qPCR (n = 3) | |
| Areg | 5.47±2.50 | 5.51±2.46 |
| Atf3 | 5.72±1.37 | 6.94±1.91 |
| IL6 | 3.20±1.36 | 3.38±2.27 |
| Hbegf | 3.76±0.73 | 4.14±1.95 |
| Egr2 | 2.92±0.74 | 3.02±1.13 |
| Myc | 3.11±0.40 | 2.96±0.49 |
| Dusp1 | 2.97±0.53 | 4.08±1.54 |
| Has2 | 2.49±0.76 | 2.56±1.23 |
| Ptgs2 | 2.37±0.63 | 4.91±1.29 |
| Jun | 2.35±0.48 | 2.40±0.08 |
| PVR | 2.04±0.49 | 2.01±0.39 |
| Epha2 | 2.02±0.41 | 1.90±0.13 |
Genes validated at both 1 and 24 h.
P<0.05.
Validation of Microarray Gene Expression at 24 h by qPCR.
| Gene | Fold change (Mean±SD) | |
| Microarray (n = 3) | RT-qPCR (n = 3) | |
| Nrn1 | 2.60±1.02 | 3.07±0.93 |
| Areg | 1.89±0.29 | 2.56±0.61 |
| Loxl2 | 2.05±0.14 | 2.57±1.37 |
| Jun | 1.25±0.20 | 1.56±0.27 |
| PVR | 1.18±0.10 | 1.44±0.31 |
| Adm | 0.46±0.18 | 0.61±0.41 |
| Egr2 | 0.40±0.13 | 0.46±0.18 |
| Fos | 0.33±0.08 | 0.35±0.06 |
Genes validated at both 1 and 24 h.
P<0.05.